Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
BOSTON, March 01, 2024 (GLOBE NEWSWIRE) — Verve Therapeutics, a clinical-stage biotechnology company pioneering a new approach to the care […]
BOSTON, March 01, 2024 (GLOBE NEWSWIRE) — Verve Therapeutics, a clinical-stage biotechnology company pioneering a new approach to the care […]
VANCOUVER, Wash., March 01, 2024 (GLOBE NEWSWIRE) — Absci Corporation (Nasdaq: ABSI) (“Absci”), a data-first generative AI drug creation company, […]
WATERTOWN, Mass., March 01, 2024 (GLOBE NEWSWIRE) — Lyra Therapeutics, Inc. (Nasdaq: LYRA) (“Lyra” or the “Company”), a clinical-stage biotechnology […]
NEW YORK, March 01, 2024 (GLOBE NEWSWIRE) — Silvercrest Asset Management Group Inc. (NASDAQ: SAMG) announced today it will host […]
ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., March 01, 2024 (GLOBE NEWSWIRE) — Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech […]
EAGLE, Idaho, March 01, 2024 (GLOBE NEWSWIRE) — The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant […]
Southfield, MI, March 01, 2024 (GLOBE NEWSWIRE) — Sun Communities, Inc. (NYSE: SUI) (the “Company”), a real estate investment trust […]
SAN CARLOS, Calif., March 01, 2024 (GLOBE NEWSWIRE) — Presto Automation Inc. (Nasdaq:PRST) (“Presto” or the “Company”), one of the […]
SALT LAKE CITY, March 01, 2024 (GLOBE NEWSWIRE) — Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology […]
CLEVELAND, March 01, 2024 (GLOBE NEWSWIRE) — As part of a recently announced five-game deal with the Cleveland Cavaliers, Gray […]